tiprankstipranks
Trending News
More News >
Cautious Outlook on Verrica Pharmaceuticals Amid Restructuring and Market Challenges
PremiumRatingsCautious Outlook on Verrica Pharmaceuticals Amid Restructuring and Market Challenges
1M ago
Hold Rating on Verrica Pharmaceuticals Amid Liquidity Concerns and Uncertain Financial Strategy
Premium
Ratings
Hold Rating on Verrica Pharmaceuticals Amid Liquidity Concerns and Uncertain Financial Strategy
1M ago
Verrica Pharmaceuticals experiences ‘strong demand-led growth’ for YCANTH in Q1
Premium
The Fly
Verrica Pharmaceuticals experiences ‘strong demand-led growth’ for YCANTH in Q1
1M ago
Verrica Pharmaceuticals Reports Positive Q4 2024 Results
PremiumCompany AnnouncementsVerrica Pharmaceuticals Reports Positive Q4 2024 Results
2M ago
Verrica Pharmaceuticals files $150M mixed securities shelf
Premium
The Fly
Verrica Pharmaceuticals files $150M mixed securities shelf
2M ago
Verrica Pharmaceuticals reports Q4 EPS (24c), consensus (24c)
Premium
The Fly
Verrica Pharmaceuticals reports Q4 EPS (24c), consensus (24c)
2M ago
Verrica announces development partner Torii files NDA for TO-208 in Japan
PremiumThe FlyVerrica announces development partner Torii files NDA for TO-208 in Japan
5M ago
Verrica Pharmaceuticals 44.96M share Spot Secondary priced at $0.89
Premium
The Fly
Verrica Pharmaceuticals 44.96M share Spot Secondary priced at $0.89
6M ago
Verrica Pharmaceuticals prices 44.96M shares at 89c in public offering
Premium
The Fly
Verrica Pharmaceuticals prices 44.96M shares at 89c in public offering
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100